$INBS' subsidiary broadens its IP portfolio with the grant of a new European patent for the Intelligent Fingerprinting DSR-Plus Cartridge Reader. This is a significant milestone in fortifying our IP portfolio and expanding into the European market.
https://t.co/H3Ut6nbjs8
$INBS preliminary unaudited fiscal Q2 & 6-month revenue results:
-YoY unaudited revenue expected to increase 337%*
-Expected 30% rise in cartridge sales & 91% rise in reader sales*
*for the 6 months ended 12/31/23 compared to the same period the prior year
https://t.co/14dSmuhgeD
Leading pan-European ferry and logistics company @POferries has adopted $INBS' Intelligent Fingerprinting Drug Screening Solution, expecting to reduce its overall #drugtesting costs by 90%.
https://t.co/L92pJSV2NL
Australasia's leading specialist material handling company @TitanCranes is the latest to adopt $INBS' Intelligent Fingerprinting #DrugScreening Solution for its 350+ employees.
https://t.co/LctViHJYac
In 2022, 100,000+ people in the US lost their lives to #opioid overdoses. 5 ways your business can help:
- Implement #drugtesting solutions
- Support employees
- Identify intoxication
- Foster a supportive workplace atmosphere
- Prioritize recovery
https://t.co/ISlx19tYZw
Key highlights from $INBS' earnings report. Strong #revenuegrowth continued with the expansion of our market presence. Completed critical development #milestone in plans to add new assays for ketamine and tramadol and advanced #expansion plan into the U.S.
$INBS PARTNERSHIP OPPORTUNITY: We're seeking motivated partners to expand our presence and distribute our #innovative#drug#screening#solution throughout the #AsiaPacific Region.
Register your interest here: https://t.co/kzk7zAOsjb
We haven’t yet seen the actual data but a 20% reduction of cardiovascular events in a 17, 500 participant randomized trial of a GLP-1 anti-obesity drug is a big deal and likely will change the reimbursement landscape (and further promote uptake)
Artificial intelligence promises great opportunities for health and healthcare delivery. Like any new technology guard rails will need to be in place. It should add to the doctor patient relationship
#artiticial Intelligence #ehealth#healthcare https://t.co/fxlMGaiB8c
This is a great article Terry @terryelvin. As a leader in any of these industries, can your organisation take the risk of not knowing of staff are affected.
#drugscreening https://t.co/OfR9RVaYMT
Did you know PLASMAIDE is an adaptogen?
An adaptogen fundamentally acts differently to a supplement.
It gets your body creating its own natural responses, which prepares and optimises your body to not only increase performance…https://t.co/0f4UrzbTyB https://t.co/UELEBY7uQd
I am very proud of the team led by Harry Simeonidis supported by Spiro Sakiris and Peter Passaris expanding our markets into the #asiapacific region.
#drugscreening#drugtesting#sweattesting https://t.co/aXPHO7v8dQ
This is a great initiative that will benefit all patients with #chronicwounds and #ulcers The catologs of products is amazing. Congratulations to Dr Marianna Prokopi-Demetriades and her team for its vision and success to date. I look forward to seeing r…https://t.co/TuS48fQNzT